BE MOBILE 2: Bimekizumab in patients with active ankylosing spondylitis
					 / Désirée van der Heijde				
				
			COVID-19 and the future management of patients with rheumatological disorders
					 / Maria-Antonietta D’Agostino				
				
			We make sure to keep you updated from EULAR 2022
					 / BestPractice Nordic				
				
			



